Skip to main content

Table 1 Characteristics of the eligible studies

From: A meta-analysis of the proportion of animal Salmonella isolates resistant to drugs used against human salmonellosis in Ethiopia

      

Number positive (%)

Author

Year

Location

Host

Ni

Amp

Sxt

Chl

Cro

Cip

MDR

[17]

1999-2000

DZ

Ct

25

13 (52)

1 (4)

0 (0)

0 (0)

0 (0)

13 (52)

[18]a

2001-2002

DJ

Cm

116

28 (24.14)

24 (20.69)

4 (3.45)

2 (1.72)

0 (0)

33 (28.45)

[19]

2003-2004

AM

Sg

22

4 (18.18)

2 (9.09)

1 (4.55)

0 (0)

0 (0)

4 (18.18)

[12]

2004-2005

DZ

Pg

94

2 (2.13)

1 (1.06)

0 (0)

0 (0)

30 (31.91)

66 (70.21)

[13]b

2004-2005

AA

Pg

173

8 (4.62)

2 (1.16)

2 (1.16)

0 (0)

7 (4.05)

55 (31.79)

[20]c

2005-2006

DZ

Ct

75

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

3 (4)

[21]

2006-2007

BD

Ct

28

2 (7.14)

Nt

1 (3.57)

Nt

Nt

3 (10.71)

[22]

2010

AA

Dc

21

21 (100)

0 (0)

2 (9.52)

0 (0)

0 (0)

14 (66.67)

  1. AA = Addis Ababa; AM = Addis Ababa and Modjo; Amp = ampicillin; BD = Bahir Dar; Chl = chloramphenicol; Cip = ciprofloxacin; Cm = slaughtered camels; Cro = ceftriaxone; Ct = slaughtered cattle; Dc = dairy cattle; DJ = Diredawa and JiJiga; DZ = Debrezeit; MDR = multi-drug resistant; Ni = number of tested isolates; Nt = not tested; Pg = slaughtered pigs; Sg = slaughtered sheep and goats; Sxt = co-trimoxazole.
  2. aData on ceftiofur was substituted for ceftriaxone.
  3. bThe numbers of co-trimoxazole, chloramphenicol and ciprofloxacin resistant isolates was extracted from the narrative part of the results and discussion section.
  4. cIsolates from holding pens were excluded.